Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 11/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8737433 | 0.90 | LMNA (0.36) | ABCB1MEN1KMT2AMAPK1SMN1; SMN2 | |
| SCHEMBL8734242 | 0.84 | GAA (0.55) | MEN1KMT2AMAPK1SMN1; SMN2ALDH1A1 | |
| SCHEMBL8735605 | 0.82 | GAA (0.52) | MAPK1SMN1; SMN2ALDH1A1LMNAHTT | |
| SCHEMBL8736808 | 0.81 | GAA (0.48) | MEN1KMT2AMAPK1SMN1; SMN2ALDH1A1 | |
| SCHEMBL13088088 | 0.80 | IGFBP3 (0.42) | MEN1KMT2AMAPK1SMN1; SMN2ALDH1A1 | |
| SCHEMBL8737430 | 0.80 | GAA (0.50) | MEN1KMT2AMAPK1SMN1; SMN2ALDH1A1 | |
| SCHEMBL8736812 | 0.78 | KCNQ3 (0.45) | MAPK1SMN1; SMN2ALDH1A1LMNAHTT | |
| SCHEMBL8735142 | 0.77 | RAB9A (0.43) | MEN1KMT2AMAPK1SMN1; SMN2ALDH1A1 | |
| SCHEMBL8735609 | 0.77 | IGFBP3 (0.37) | MEN1KMT2AMAPK1SMN1; SMN2ALDH1A1 | |
| SCHEMBL30043102 | 0.75 | KCNQ3 (0.43) | MAPK1SMN1; SMN2ALDH1A1LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120130117-A1 | AROMATIC SULFONIUM SALT COMPOUND | ADEKA CORPORATION (JP) | 2012-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120130117-A1 | AROMATIC SULFONIUM SALT COMPOUND | SLC6A19, ARSA, PAH | ABCB1 2928/4885MEN1 3308/4885KMT2A 1675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.